London, United Kingdom

Samuel David Parkinson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Drayson Technologies (Europe) Limited. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel David Parkinson. Retrieved from https://idiyas.com/inventor/samuel-david-parkinson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Samuel David Parkinson: Innovator in Health Technology

Introduction

Samuel David Parkinson is a notable inventor based in London, Greater London, GB. He is currently associated with Sensyne Health Group Limited, a company focused on leveraging artificial intelligence to improve healthcare outcomes. Despite having no patents to his name, Parkinson's contributions to the field of health technology are significant.

Latest Patents

As of now, Samuel David Parkinson holds 1 patents. This indicates that his work may be more focused on research and development rather than patenting inventions.

Career Highlights

Parkinson has made strides in the health technology sector through his role at Sensyne Health Group Limited. His work involves collaborating with healthcare providers to enhance patient care using innovative technology solutions.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Samuel David Parkinson is an influential figure in health technology, contributing to advancements that aim to improve healthcare delivery. His work at Sensyne Health Group Limited showcases his commitment to innovation in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…